Genmab stock surges 11% on positive cancer drug trial data

🇩🇰 Investing.com (DK) —
Genmab stock surges 11% on positive cancer drug trial data

AI Summary

Genmab shares rose 11% after the company reported positive data from a cancer drug trial. The result links clinical research news with a substantial market reaction.

Markets Health Genmab cancer drug clinical trial positive trial data stock surge

Read original source →